Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | GABRD | O14764 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30984509 | 0.98 | CYP1A2 (0.42) | CYP1A2GABRDGABRA1GABRB1GABRA5 | |
| SCHEMBL1780077 | 0.84 | LMNA (0.43) | LMNAMAPK1RAB9A | |
| Hydrochloric Acid SCHEMBL20488405 | 0.82 | LMNA (0.42) | LMNAMAPK1RAB9A | |
| SCHEMBL30736784 | 0.79 | GPR119 (0.44) | CYP2D6LMNAMAPK1RAB9A | |
| SCHEMBL27282761 | 0.79 | CYP1A2 (0.44) | CYP1A2CYP2D6LMNAMAPK1RAB9A | |
| SCHEMBL30592964 | 0.78 | CA2 (0.42) | LMNAMAPK1RAB9A | |
| Trifluoroacetic Acid SCHEMBL18497410 | 0.78 | LMNA (0.45) | LMNAMAPK1RAB9A | |
| SCHEMBL20101964 | 0.78 | LMNA (0.44) | CYP1A2CYP2D6LMNAMAPK1RAB9A | |
| Morpholine SCHEMBL8023056 | 0.76 | TSHR (0.50) | LMNAMAPK1RAB9A | |
| SCHEMBL21409258 | 0.75 | LMNA (0.54) | CYP1A2GABRDGABRA1GABRB1GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561575-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |